TP53 and hepatocellular carcinoma: In contrast, existing literature, such as the study on Viramidine-loaded aptamer-nanoparticles, illustrates a distinct therapeutic paradigm targeting the CDC25A/p53/PI3k pathway to induce cell cycle arrest in hepatoma cells28.